Comparison of Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Endovascular Procedures of Cerebrovascular Disorders: A Single-center,Randomized,Single-blind, Non-inferiority Trial
Latest Information Update: 21 Oct 2022
At a glance
- Drugs Remimazolam (Primary)
- Indications Anaesthesia
- Focus Therapeutic Use
- Acronyms REPEAT
- 19 Oct 2022 Status changed from recruiting to completed.
- 25 May 2022 Status changed from not yet recruiting to recruiting.
- 13 Jul 2021 New trial record